Defunct Company
Total Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
378
NCT02037269
LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2014
Completion: Jul 31, 2016
NCT02151097
PRIME - PRostate Imaging for Margin Evaluation
Start: Nov 30, 2014
Completion: Jun 30, 2016
NCT02666079
The LightPath® Breast Cancer Study
Start: May 1, 2017
Completion: Dec 31, 2018
NCT02151071
The Breast Surgery EnLight and LightPath Imaging System Study
Phase: Phase 1/2
Start: Sep 30, 2017
Completion: Sep 30, 2019
NCT03731026
The LightPath® and 68Ga-RM2 in Breast Cancer Study
Phase: Phase 3
Start: Nov 30, 2018
Completion: Nov 30, 2023
NCT04632251
Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer
Start: Sep 16, 2020
Completion: Aug 31, 2021
NCT05346458
Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor
Role: Collaborator
Start: Dec 14, 2022
Completion: Oct 3, 2023